Signum Life Science ApS: Financial statements 2019
CVR: 36559241
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 10,457,442 and a net result of DKK 3,795,326 compared with DKK 4,067,570 the year before. That is a decrease of 13.1% compared with the year before. Equity in the 2019 report amounted to DKK 129,178,418. The solvency ratio was 81.2%. The company had 28 employees in the financial year.
- Gross Profit
- DKK 10,457,442
- Profit/Loss
- DKK 3,795,326
- Equity
- DKK 129,178,418
- Total Assets
- DKK 159,181,165
- Employees
- 28
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 10.5M | 3.8M | 129.2M | 28 |
| 2018 | - | 12M | 4.1M | 127.5M | 21 |
| 2017 | - | 12.5M | 5.5M | 125.8M | - |
| 2016 | - | 11.4M | 4.8M | 122.5M | 16 |
| 2015 | - | 9.2M | 2.6M | 119.5M | 16 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of November 1, 2019, Thomas Bo Bjørn Klee has joined the board of directors of Signum Life Science ApS.
As of November 1, 2019, Lars Møller has joined the board of directors of Signum Life Science ApS.
As of November 1, 2019, Mads Veggerby Lausten has left the board of directors of Signum Life Science ApS.
As of October 31, 2019, Lars Møller has left the board of directors of Signum Life Science ApS.
As of June 21, 2019, Mads Veggerby Lausten has joined the board of directors of Signum Life Science ApS.
As of June 21, 2019, Andreas Daugaard Jørgensen has joined the board of directors of Signum Life Science ApS.
As of June 21, 2019, Christoffer Dahl has left the board of directors of Signum Life Science ApS.
As of June 20, 2019, Mads Veggerby Lausten has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2018. Gross profit came to DKK 12,039,531, and the net result was DKK 4,067,570.
As of April 3, 2019, Lars Møller has joined the board of directors of Signum Life Science ApS.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
